CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) saw a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 4,800 shares, a decrease of 25.0% from the February 13th total of 6,400 shares. Based on an average daily volume of 8,600 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.1% of the company’s shares are sold short.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. HC Wainwright restated a “buy” rating and set a $11.00 target price on shares of CollPlant Biotechnologies in a research report on Friday, November 29th. D. Boral Capital restated a “buy” rating and set a $14.00 price objective on shares of CollPlant Biotechnologies in a report on Wednesday, February 12th.
View Our Latest Report on CollPlant Biotechnologies
Institutional Trading of CollPlant Biotechnologies
CollPlant Biotechnologies Price Performance
Shares of CLGN opened at $3.30 on Tuesday. The firm has a market capitalization of $37.76 million, a price-to-earnings ratio of -2.14 and a beta of 1.07. The company has a 50-day moving average of $3.66 and a 200 day moving average of $4.06. CollPlant Biotechnologies has a 1-year low of $3.00 and a 1-year high of $6.75.
CollPlant Biotechnologies Company Profile
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.
Featured Stories
- Five stocks we like better than CollPlant Biotechnologies
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Can TikTok Stock Picks Really Make You Rich?
- What Does a Stock Split Mean?
- The “Quality” Rotation: Back to Basics Investing
- What Are the U.K. Market Holidays? How to Invest and Trade
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for CollPlant Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CollPlant Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.